A consensus on the diagnosis and treatment of acromegaly complications.
In March 2011, the Acromegaly Consensus Group met to revise and update the guidelines on the diagnosis and treatment of acromegaly complications. The meeting was sponsored by the Pituitary Society and the European Neuroendocrinology Association and included experts skilled in the management of acromegaly. Complications considered included cardiovascular, endocrine and metabolic, sleep apnea, bone diseases, and mortality. Outcomes in selected, related clinical conditions were also considered, and included pregnancy, familial acromegaly and invasive macroadenomas. The need for a new disease staging model was considered, and design of such a tool was proposed.
Department of Medicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Room 2015, Los Angeles, CA 90048, USA. Shlomo.Melmed@cshs.org
S
S
Melmed
F F
FF
Casanueva
A
A
Klibanski
M D
MD
Bronstein
P
P
Chanson
S W
SW
Lamberts
C J
CJ
Strasburger
J A H
JA
Wass
A
A
Giustina
D000172:Acromegaly / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D001847:Bone Diseases / Q000209:etiology; D002318:Cardiovascular Diseases / Q000209:etiology; D004700:Endocrine System Diseases / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000209:etiology; D012891:Sleep Apnea Syndromes / Q000209:etiology